Literature DB >> 7021604

Carriage of group B streptococci in the upper respiratory tract.

C G Cummings, P W Ross.   

Abstract

Mesh：

Year:  1981        PMID： 7021604      PMCID： PMC493832          DOI： 10.1136/jcp.34.7.813-a

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  6 in total

1.  Occurrence of groupable beta-hemolytic streptococci. Study among school children in Bismarck, N.D.

Authors:  W C NICHOLAS; C P STEELE
Journal:  JAMA       Date:  1962-07-21       Impact factor: 56.272

2.  Group B beta-hemolytic streptococci causing pharyngitis.

Authors:  J H Chretien; C G McGinniss; J Thompson; E Delaha; V F Garagusi
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

3.  Safety cabinet for use in laboratory studies on hazardous infectious diseases.

Authors:  D A Rutter
Journal:  Br Med J       Date:  1977-07-02

4.  Evaluation of bacteriological swabs and transport media in the recovery of group B streptococci on laboratory media.

Authors:  C G Cumming; P W Ross
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

5.  Vervet monkey disease: studies on some physical and chemical properties of the causative agent.

Authors:  E T Bowen; D I Simpson; W F Bright; I Zlotnik; D M Howard
Journal:  Br J Exp Pathol       Date:  1969-08

6.  Use of the Streptosec test for grouping beta-haemolytic streptococci.

Authors:  P W Ross; A Nicoll; C G Cumming
Journal:  J Clin Pathol       Date:  1980-07       Impact factor: 3.411
  6 in total
  2 in total

1.  Molecular characterization of human-colonizing Streptococcus agalactiae strains isolated from throat, skin, anal margin, and genital body sites.

Authors:  Nathalie van der Mee-Marquet; Laure Fourny; Laurence Arnault; Anne-Sophie Domelier; Mazen Salloum; Marie-Frédérique Lartigue; Roland Quentin
Journal:  J Clin Microbiol       Date:  2008-07-16       Impact factor: 5.948

2.  Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients.

Authors:  Vera Eickel; Barbara Kahl; Beatrice Reinisch; Angelika Dübbers; Peter Küster; Claudia Brandt; Barbara Spellerberg
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.